Víctor Manuel Peña

Prof. Dr. Víctor Manuel Peña


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 June 2018 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
MSMario Simental-Mendía
Mario Simental-Mendía
ASAdriana Sánchez-García
Adriana Sánchez-García
FVFelix Vílchez-Cavazos
Felix Vílchez-Cavazos
CACarlos Acosta-Olivo
Carlos Acosta-Olivo
VPVíctor Manuel Peña
Víctor Manuel Peña
LSLuis E. Simental-Mendía
Luis E. Simental-Mendía

3 May 2021 in International Orthopaedics
Verified
Journal Article
Closed access
PDF file
CACarlos Acosta-Olivo
Carlos Acosta-Olivo
FVFelix Vílchez-Cavazos
Felix Vílchez-Cavazos
JBJaime Blázquez-Saldaña
Jaime Blázquez-Saldaña
GVGregorio Villarreal-Villarreal
Gregorio Villarreal-Villarreal
VPVíctor Manuel Peña
Víctor Manuel Peña
MSMario Simental-Mendía
Mario Simental-Mendía

26 February 2020 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
MSMario Simental-Mendía
Mario Simental-Mendía
FVFelix Vílchez-Cavazos
Felix Vílchez-Cavazos
NÁNeri Alejandro Álvarez-Villalobos
Neri Alejandro Álvarez-Villalobos
JBJaime Blázquez-Saldaña
Jaime Blázquez-Saldaña
VPVíctor Manuel Peña
Víctor Manuel Peña
CACarlos Acosta-Olivo
Carlos Acosta-Olivo

Verified
Journal Article
Open access
PDF file
VSVanessa Perez Silos
Vanessa Perez Silos
NMNidia K. Moncada-Saucedo
Nidia K. Moncada-Saucedo
VPVíctor Manuel Peña
Víctor Manuel Peña
JLJorge Lara-Arias
Jorge Lara-Arias
IMIván A. Marino-Martínez
Iván A. Marino-Martínez
LFLizeth Fuentes
Lizeth Fuentes
In cartilage tissue engineering, biphasic scaffolds (BSs) have been designed not only to influence the recapitulation of the osteochondral architecture but also to take advantage of the healing ability of bone, promoting the implant’s integration with the surrounding tissue and then bone restoration and cartilage regeneration. This study reports the development and characterization of a BS based on the assembly of a cartilage phase constituted by fibroin biofunctionalyzed with a bovine cartilage matrix, cellularized with differentiated autologous pre-chondrocytes and well attached to a bone phase (decellularized bovine bone) to promote cartilage regeneration in a model of joint damage in pigs. BSs were assembled by fibroin crystallization with methanol, and the mechanical features and histological architectures were evaluated. The scaffolds were cellularized and matured for 12 days, then implanted into an osteochondral defect in a porcine model (n = 4). Three treatments were applied per knee: Group I, monophasic cellular scaffold (single chondral phase); group II (BS), cellularized only in the chondral phase; and in order to study the influence of the cellularization of the bone phase, Group III was cellularized in chondral phases and a bone phase, with autologous osteoblasts being included. After 8 weeks of surgery, the integration and regeneration tissues were analyzed via a histology and immunohistochemistry evaluation. The mechanical assessment showed that the acellular BSs reached a Young’s modulus of 805.01 kPa, similar to native cartilage. In vitro biological studies revealed the chondroinductive ability of the BSs, evidenced by an increase in sulfated glycosaminoglycans and type II collagen, both secreted by the chondrocytes cultured on the scaffold during 28 days. No evidence of adverse or inflammatory reactions was observed in the in vivo trial; however, in Group I, the defects were not reconstructed. In Groups II and III, a good integration of the implant with the surrounding tissue was observed. Defects in group II were fulfilled via hyaline cartilage and normal bone. Group III defects showed fibrous repair tissue. In conclusion, our findings demonstrated the efficacy of a biphasic and bioactive scaffold based on silk fibroin and cellularized only in the chondral phase, which entwined chondroinductive features and a biomechanical capability with an appropriate integration with the surrounding tissue, representing a promising alternative for osteochondral tissue-engineering applications.

23 October 2022 in The Journal of Foot and Ankle Surgery
Verified
Journal Article
Closed access
PDF file
GVGregorio Alejandro Villarreal-Villarreal
Gregorio Alejandro Villarreal-Villarreal
MSMario Simental-Mendía
Mario Simental-Mendía
AAAugusto Andres Gamboa Alonso
Augusto Andres Gamboa Alonso
FVFélix Vilchez-Cavazos
Félix Vilchez-Cavazos
CACarlos Alberto Acosta-Olivo
Carlos Alberto Acosta-Olivo
VPVíctor Manuel Peña
Víctor Manuel Peña

Verified
Journal Article
Open access
PDF file
ÁAÁngel Arnaud-Franco
Ángel Arnaud-Franco
JLJorge Lara-Arias
Jorge Lara-Arias
IMIván A. Marino-Martínez
Iván A. Marino-Martínez
OCOscar Cienfuegos-Jiménez
Oscar Cienfuegos-Jiménez
ÁBÁlvaro Barbosa-Quintana
Álvaro Barbosa-Quintana
VPVíctor Manuel Peña
Víctor Manuel Peña
Background: Achilles-tendon rupture prevails as a common tendon pathology. Adipose-derived mesenchymal stem cells (ADMSCs) are multipotent stem cells derived from adipose tissue with attractive regeneration properties; thus, their application in tendinopathies could be beneficial. Methods: Male rabbit ADMSCs were obtained from the falciform ligament according to previously established methods. After tenotomy and suture of the Achilles tendon, 1 × 106 flow-cytometry-characterized male ADMSCs were injected in four female New Zealand white rabbits in the experimental group (ADMSC group), whereas four rabbits were left untreated (lesion group). Confirmation of ADMSC presence in the injured site after 12 weeks was performed with quantitative sex-determining region Y (SRY)-gene RT-PCR. At Week 12, histochemical analysis was performed to evaluate tissue regeneration along with quantitative RT-PCR of collagen I and collagen III mRNA. Results: Presence of male ADMSCs was confirmed at Week 12. No statistically significant differences were found in the histochemical analysis; however, statistically significant differences between ADMSC and lesion group expression of collagen I and collagen III were evidenced, with 36.6% and 24.1% GAPDH-normalized mean expression, respectively, for collagen I (p < 0.05) and 26.3% and 11.9% GAPDH-normalized mean expression, respectively, for collagen III (p < 0.05). The expression ratio between the ADMSC and lesion group was 1.5 and 2.2 for collagen I and collagen III, respectively. Conclusion: Our results make an important contribution to the understanding and effect of ADMSCs in Achilles-tendon rupture.